Each 1 g of paste contains 187.50 mg of Fenbendazole
For the treatment of immature and mature stages of roundworms: bloodworms (large strongyles), redworms (small strongyles), ascarids, oxyurids and strongyloides of horses.
Dosage and route of administration
The syringe is graduated with 6 markings. Each marking corresponds to a dosage for 100 kg body weight.
Before administration, the syringe should be adjusted to the calculated dosage by setting the ring on the plunger.
Ensure that the horse does not have food in its mouth.
Insert the syringe in the gap between the front and back teeth and deliver paste onto the back of the tongue.
Immediately raise the horse’s head for a few seconds after dosing.
The recommended dosage is 7.5 mg fenbendazole/kg body weight. One syringe contains sufficient paste to treat one 600 kg horse.
Diarrhoea caused by Strongyloides westeri in sucking foals should be treated with a dose of 50 mg fenbendazole/kg body weight corresponding to 24 g (contents of 1 syringe) for 90 kg body weight.
- Additional Information
SKU 66070 Tax Class 9% Brand MSD Intervet Route of Administration Oral Active Ingredient Fenbendazole 187.50 mg/g Withdrawal period Not to be used in horses intended for human consumption Target Species Horses Registrationnumber REG NL 8663 Kanalisatie URA Units per outerbox 10 Veterinary Advice Do not use in horses intended for human consumption. Operator warnings Direct contact with the skin should be kept to a minimum. Wash hands after use. Environmental warnings Dispose of any unused product and empty sachets in accordance with guidance from your local waste regulation authority. For animal treatment only. Keep out of reach of children. Assess bodyweight as accurately as possible before calculating the dosage. Ingredients 'Uses A broad-spectrum anthelmintic for the treatment and control of adult and immature roundworms of the gastro-intestinal tract in horses and other equines. Panacur also has an ovicidal effect on nematode eggs. Horses Panacur effectively treats and controls the following roundworm infections: -Large strongyles (adults and migrating larval stages of S. vulgaris; adults and tissue larval stages of S. edentatus). -Adult and immature small strongyles (Cyathostomes) (benzimidazole susceptible) including encysted mucosal 3rd and 4th stage larvae; it is also effective against inhibited 3rd stage larvae (encysted) in the mucosa. -Adult and immature Oxyuris spp., Strongyloides spp. and Parascaris equorum. 1 g Panacur Equine Granules contains 0.22 g active ingredient'
Instructions for use Dosage and administration For routine treatment of horses administer orally 5 g Panacur Equine Granules per 150 kg bodyweight. (= 7.5 mg fenbendazole/kg bodyweight) Single dose treatments For the treatment and control of encysted mucosal stages of small strongyles, administer 20g Panacur Equine Granules per 150kg bodyweight (=30mg fenbendazole /kg bodyweight)Increased dosing for specific infections Five day course For the treatment and control of migrating larval and tissue stages of large strongyles, administer 40g Panacur Equine Granules per 150 kg bodyweight (=60mg fenbendazole /kg bodyweight) All horses should be routinely wormed with the single dose of Panacur Equine Granules every 6-8 weeks. Treatment of encysted mucosal dwelling larvae should ideally be done in the autumn (late October/November) and again in the Spring. However, for horses that fail to maintain condition or bought-in horses with unknown worming history, the treatment can be given at any time of the year.